Middle-Aged Adults Taking GLP-1s Could Cut Medical Costs
A fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
Learn which low fee index funds beat the market in 2024 and how they can fit into a retirement strategy. This guide highlights top performers and practical steps for investors.
28,527 articlesA fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
Alphabet is famous for growth, not income. A new high-yield option—mandatory convertible preferred shares GOOGM and G...
As 2026 unfolds, Caesars Entertainment and Six Flags chart different courses in the leisure market. This guide breaks...
With crude hovering near $70, some investors wonder if energy stocks can keep delivering. This article explains why t...
Compass Point flags three financials fresh ratings: wall on UWMC, RKT, and SLRC as rates ease and lending activity is...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Strategy Inc. raised hundreds of millions by selling new common stock to buy bitcoin, while Michael Saylor posted a r...
As the US Treasury aims to rebuild its cash balance toward 900B by June, Bitcoin traders face a potential liquidity s...
FuelCell Energy priced a $225 million stock offering at $21 per share, triggering a 14% slide and dragging peers Bloo...
Markets recalibrate after a run by the Magnificent Seven, pushing many to rethink concentration. Three ETFs—RSP, SCHV...
The SPDR S&P Semiconductor ETF jumps roughly 12% amid resilient AI-related demand, yet Intel remains a weakness in an...
Harvard's endowment disclosed a pivot in its crypto holdings, selling a Bitcoin ETF stake and buying Ethereum as mark...